Table 2.

The Effects of Inclusion of American College of Obstetricians and Gynecologists–Recommended Counseling Elements and Other Elements of Provider Counseling on Maternal Decision for and Completion of Screening Tests for Fetal Aneuploidy

Counseling Element	Conversations Including Counseling Element (n=190)	Patients Choosing Screening After Counseling	P*	Patients Completing Screening Test After Counseling	P
Counseling Elements Recommended by ACOG:
Detection Rate	2 (1.1)	2/2 (100)	1.0	2/2 (100)	1.0
False Positive Rate	3 (1.6)	2/3 (66.6)	0.56	2/3 (66.6)	0.82
Advantages	104 (54.7)	84/104 (80.8)	0.19	77/104 (74.0)	0.62
Disadvantages or Limitations	92 (48.7)	69/92 (75.0)	0.87	67/92 (72.8)	0.89
Availability of Diagnostic Testing	73 (35.3)	53/73 (72.6)	0.27	52/73 (71.2)	0.96
Reviews the screening process	163 (85.8)	130/163 (79.8)	0.049	118/163 (72.4)	0.87
Gives a woman’s baseline (age-based) risk	55 (29.1)	39/55 (70.9)	0.07	42/55 (76.4)	0.42
Explains what is Down Syndrome	38 (20.0)	26/38 (68.4)	0.35	26/38 (68.4)	0.51
Explains that screening tests also screen for Trisomy 18	49 (25.8)	40/49 (81.6)	0.34	39/49 (79.6)	0.21
Explains that screening results are not diagnostic	97 (51.1)	73/97 (75.3)	0.86	72/97 (74.2)	0.58
Emphasizes that screening is optional	85 (44.7)	56/85 (65.9)	0.002	58/85 (68.2)	0.20
Discusses the option of pregnancy termination if results are abnormal	31 (16.3)	22/31 (71.0)	0.29	19/31 (61.3)	0.13
Discusses how screening results might be useful to a patient (reassurance, diagnostic testing, termination, etc.)	71 (37.4)	54/71 (76.1)	0.75	52/71 (73.2)	0.88

^*Patients who were undecided at the time of visit included with patients who declined screening in this analysis

Data are n (%) or n/n (%)

P values based on logistic regression with generalized estimating equations